CN111214598A - A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain, and rheumatalgia - Google Patents
A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain, and rheumatalgia Download PDFInfo
- Publication number
- CN111214598A CN111214598A CN202010075986.4A CN202010075986A CN111214598A CN 111214598 A CN111214598 A CN 111214598A CN 202010075986 A CN202010075986 A CN 202010075986A CN 111214598 A CN111214598 A CN 111214598A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw
- sprain
- traumatic injury
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain. The traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises effective components and/or pharmaceutically acceptable excipient, wherein the raw materials for preparing the effective components comprise: 1-5 parts of raw arisaema tuber; 2-4 parts of raw pinellia ternate; 4-8 parts of raw radix aconiti; 3-6 parts of raw frankincense; 3-7 parts of philippine flemingia roots; 4-9 parts of erythrina bark; 1-3 parts of lycopodium clavatum; 2-5 parts of kadsura pepper stems; 2-5 parts of safflower; 4-9 parts of peach red; 3-7 parts of a powder medicine; 3-5 parts of angelica tail; 4-9 parts of clove; 3-7 parts of herba lycopi; 1-3 parts of radix angelicae pubescentis; 5-10 parts of cassia twig; 2-5 parts of camphor; and 2-6 parts of borneol. The traditional Chinese medicine composition for treating tendons relaxing and activating, traumatic injury and sprain and rheumatism bone pain provided by the invention can be used in four seasons, and is time-saving, labor-saving and quick in cure aiming at sprain caused by iron, rheumatism bone pain, neck, shoulder, waist and leg pain.
Description
Technical Field
The invention relates to a traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain.
Background
In order to relieve pain and suffering of patients and avoid the burden of hospital cost, most patients choose oral medicines for conditioning, the laziness of medicines is generated by long-term medicine suction conditioning, and the side effects of the medicines on the body are accumulated continuously, so that various complications can be caused, such as: liver disease, kidney disease, bone degenerative disease, and the like.
The eighteenth volume of the Chinese patent medicine preparation of the ministry of health of the people's republic of China, page 73-74, discloses a prescription of bone setting water, which is prepared from kadsura longepedunculata, elecampane, caulis piperis, ground beetle, aquilaria sinensis, gleditsia sinensis lam, cortex acanthopanacis, curcuma zedoary, double-iron wire, entada japonica, corious eleutherine rhizome, paniculate swallowwort root, rosewood heart wood, Japanese ardisia root, inula herb, polygonum cuspidatum, kadsura pepper stem, philippine flemingia root, ardisia crenata sim, radix transversonalis, chuanfeng, radix aconiti agrestis, menthol and camphor. The amounts of the components are not disclosed. CN1362129A entitled NANOCENTAIZHENGGU preparation medicine and its preparation method discloses that the preparation is prepared from radix aucklandiae, caulis Piperis Kadsurae, radix et rhizoma Gaultheriae Yunnanensis, Eupolyphaga Seu Steleophaga, cortex Periplocae Radicis, Curcumae rhizoma, caulis Endadae Phaseoloidis, lignum Dalbergiae Odoriferae, radix Zanthoxyli, radix Flemingiae Philippinensis, radix Ardisiae Crenatae, radix Callicarpae Longissimae, radix Zanthoxyli, radix Aconiti Kusnezoffii, Mentholum, Camphora, radix Aristolochiae, fructus Gleditsiae Abnormalis, radix Clematidis, cortex Lycii, and radix Cynanch. Although the dosage of the raw materials is disclosed, the prescription has different medicinal flavors. The present invention has been accomplished by adjusting the formulation and optimizing the amounts of the respective components to obtain a better therapeutic effect.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a traditional Chinese medicine composition for treating tendon relaxing and collateral activating, traumatic injury and sprain and rheumatic bone pain, and provides a preferable traditional Chinese medicine composition.
In order to achieve the purpose, the invention provides the following technical scheme:
a traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises effective components and/or pharmaceutically acceptable excipient, wherein the raw materials for preparing the effective components comprise: 1-5 parts of raw arisaema tuber; 2-4 parts of raw pinellia ternate; 4-8 parts of raw radix aconiti; 3-6 parts of raw frankincense; 3-7 parts of philippine flemingia roots; 4-9 parts of erythrina bark; 1-3 parts of lycopodium clavatum; 2-5 parts of kadsura pepper stems; 2-5 parts of safflower; 4-9 parts of peach red; 3-7 parts of a powder medicine; 3-5 parts of angelica tail; 4-9 parts of clove; 3-7 parts of herba lycopi; 1-3 parts of radix angelicae pubescentis; 5-10 parts of cassia twig; 2-5 parts of camphor; and 2-6 parts of borneol.
A traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises the following raw materials for preparing active ingredients: 5 parts of raw arisaema tuber; 4 parts of raw pinellia ternate; 6 parts of raw radix aconiti; 4 parts of raw frankincense; 4 parts of philippine flemingia roots; 5 parts of erythrina bark; 2 parts of lycopodium clavatum; 2 parts of caulis piperis futokadsurae; 4 parts of safflower; 5 parts of peach red; 4 parts of powder medicine; 4 parts of Chinese angelica root; 4 parts of clove; 5 parts of herba lycopi; 2 parts of radix angelicae pubescentis; 6 parts of cassia twig; 4 parts of camphor; 3 parts of borneol.
A traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises the following raw materials for preparing active ingredients: 5 parts of raw arisaema tuber; 3 parts of raw pinellia ternate; 5 parts of raw radix aconiti; 5 parts of raw frankincense; 4 parts of philippine flemingia roots; 5 parts of erythrina bark; 2 parts of lycopodium clavatum; 3 parts of kadsura pepper stem; 3 parts of safflower; 4 parts of peach red; 4 parts of powder medicine; 4 parts of Chinese angelica root; 4 parts of clove; 3 parts of herba lycopi; 3 parts of radix angelicae pubescentis; 8 parts of cassia twig; 4 parts of camphor; and 2 parts of borneol.
A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain and rheumatalgia is prepared from effective components and pharmaceutically acceptable adjuvants by making into topical liquid preparation, spray, pellicle, unguent, powder or gel.
The invention has the beneficial effects that: the traditional Chinese medicine composition for treating tendons relaxing and activating, traumatic injury and sprain and rheumatic pain, provided by the invention, has the advantages that the traumatic injury and sprain, the swelling diminishing and pain relieving, the rheumatic pain, cervical spondylosis, scapulohumeral periarthritis, lumbar disc herniation and other symptoms can be used in four seasons, the traditional Chinese medicine composition can be used for treating iron sprain, the rheumatic pain, neck, shoulder, waist and leg pain, the treatment is quick, the time and the labor are saved, the powder and the liquid spray are adopted, meanwhile, the medicine is applied to an affected part and covered by a preservative film, the pain is relieved after being heated by a baking lamp for two hours, and seven days are a treatment course.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means and effects of the present invention, the following detailed description is given with reference to the preferred embodiments of the present invention.
A traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises effective components and/or pharmaceutically acceptable excipient, wherein the raw materials for preparing the effective components comprise: 1-5 parts of raw arisaema tuber; 2-4 parts of raw pinellia ternate; 4-8 parts of raw radix aconiti; 3-6 parts of raw frankincense; 3-7 parts of philippine flemingia roots; 4-9 parts of erythrina bark; 1-3 parts of lycopodium clavatum; 2-5 parts of kadsura pepper stems; 2-5 parts of safflower; 4-9 parts of peach red; 3-7 parts of a powder medicine; 3-5 parts of angelica tail; 4-9 parts of clove; 3-7 parts of herba lycopi; 1-3 parts of radix angelicae pubescentis; 5-10 parts of cassia twig; 2-5 parts of camphor; and 2-6 parts of borneol.
Example 1:
a traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises the following raw materials for preparing active ingredients: 5 parts of raw arisaema tuber; 4 parts of raw pinellia ternate; 6 parts of raw radix aconiti; 4 parts of raw frankincense; 4 parts of philippine flemingia roots; 5 parts of erythrina bark; 2 parts of lycopodium clavatum; 2 parts of caulis piperis futokadsurae; 4 parts of safflower; 5 parts of peach red; 4 parts of powder medicine; 4 parts of Chinese angelica root; 4 parts of clove; 5 parts of herba lycopi; 2 parts of radix angelicae pubescentis; 6 parts of cassia twig; 4 parts of camphor; 3 parts of borneol.
Example 2:
a traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain comprises the following raw materials for preparing active ingredients: 5 parts of raw arisaema tuber; 3 parts of raw pinellia ternate; 5 parts of raw radix aconiti; 5 parts of raw frankincense; 4 parts of philippine flemingia roots; 5 parts of erythrina bark; 2 parts of lycopodium clavatum; 3 parts of kadsura pepper stem; 3 parts of safflower; 4 parts of peach red; 4 parts of powder medicine; 4 parts of Chinese angelica root; 4 parts of clove; 3 parts of herba lycopi; 3 parts of radix angelicae pubescentis; 8 parts of cassia twig; 4 parts of camphor; and 2 parts of borneol.
The preparation method comprises the following steps:
a Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain and rheumatalgia is prepared from effective components and pharmaceutically acceptable adjuvants by making into topical liquid preparation, spray, pellicle, unguent, powder or gel.
Clinical application example 5:
case one: the disease condition is not improved after being delivered to county-level hospital for ten days after the patient is discharged from the hospital and introduced to the sanitary station by friends for treatment, the purple extravasated blood of the right knee joint of the patient is not resolved, the swelling of the right knee joint of the patient is relieved after the patient is taken at the sanitary station for three days, the purple extravasated blood disappears, and the patient can recover after five days of drug treatment.
Case two: a certain wheat, a woman is 67 years old, the lumbar hyperplasia disease history is over years, waist soreness, leg and foot numbness is over years, no obvious effect is seen in treatment in most families and three hospitals, sudden pain is caused in No. 2 and 16 in 2015, the patient cannot walk actively, through DR examination, lumbar disc herniation and L4 vertebral dislocation are obtained, through recommendation of friends to the health station for treatment, after manual reduction, the patient is pressed on an affected part by using the liquid medicine of the formula, the liquid medicine of the formula is mixed uniformly and applied to the affected part and covered by a preservative film, a baking lamp is heated for 2 hours, the patient can cure the disease by himself on the next day, the disease is successfully cured after 10 days of treatment, and the disease is not relapsed.
The method is characterized in that: quickly reaches the focus, has strong penetrating power, repairs and damages periosteum and bone, recovers articular cartilage, and achieves the functions of relaxing tendons and activating collaterals, promoting blood circulation and removing blood stasis, warming channels and dispelling cold.
The invention clinically observes 100 patients from 2016 to 2019, and the clinical report is as follows:
the treatment method comprises the following steps:
the traditional Chinese medicine composition of the embodiment 2 is prepared into powder by a conventional process, 1 dose is taken every day, and 7 days are 1 course of treatment.
The curative effect standard is as follows:
and (3) curing: the symptoms completely disappear, and the disease does not relapse within 3 months after the treatment is stopped.
Remarkably: the symptoms are obviously improved and basically recovered to be normal, but relapse occasionally or relapse after stopping the medicine for 3 months.
The method has the following advantages: the symptoms are reduced, and the symptoms are not completely improved after 3 months of use.
And (4) invalidation: after the medicine is taken, the symptoms are not obviously changed or the symptoms are aggravated.
The treatment results are as follows:
in 100 patients, 64 patients are cured (64%), 18 patients are obviously effective (18%), 10 patients are improved (10%), 8 patients are not effective (8%), and the total effective rate is 92.0%.
The above description is only for the specific embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (4)
1. A traditional Chinese medicine composition for treating tendons relaxing and activating collaterals, traumatic injury and sprain and rheumatism bone pain is characterized by comprising effective components and/or pharmaceutically acceptable excipients, wherein the raw materials for preparing the effective components comprise: 1-5 parts of raw arisaema tuber; 2-4 parts of raw pinellia ternate; 4-8 parts of raw radix aconiti; 3-6 parts of raw frankincense; 3-7 parts of philippine flemingia roots; 4-9 parts of erythrina bark; 1-3 parts of lycopodium clavatum; 2-5 parts of kadsura pepper stems; 2-5 parts of safflower; 4-9 parts of peach red; 3-7 parts of a powder medicine; 3-5 parts of angelica tail; 4-9 parts of clove; 3-7 parts of herba lycopi; 1-3 parts of radix angelicae pubescentis; 5-10 parts of cassia twig; 2-5 parts of camphor; and 2-6 parts of borneol.
2. The traditional Chinese medicine composition for treating tendons and collaterals relaxing, traumatic injury and sprain and rheumatalgia as claimed in claim 1, wherein the raw materials for preparing the effective components comprise: 5 parts of raw arisaema tuber; 4 parts of raw pinellia ternate; 6 parts of raw radix aconiti; 4 parts of raw frankincense; 4 parts of philippine flemingia roots; 5 parts of erythrina bark; 2 parts of lycopodium clavatum; 2 parts of caulis piperis futokadsurae; 4 parts of safflower; 5 parts of peach red; 4 parts of powder medicine; 4 parts of Chinese angelica root; 4 parts of clove; 5 parts of herba lycopi; 2 parts of radix angelicae pubescentis; 6 parts of cassia twig; 4 parts of camphor; 3 parts of borneol.
3. The traditional Chinese medicine composition for treating tendons and collaterals relaxing, traumatic injury and sprain and rheumatalgia as claimed in claim 1, wherein the raw materials for preparing the effective components comprise: 5 parts of raw arisaema tuber; 3 parts of raw pinellia ternate; 5 parts of raw radix aconiti; 5 parts of raw frankincense; 4 parts of philippine flemingia roots; 5 parts of erythrina bark; 2 parts of lycopodium clavatum; 3 parts of kadsura pepper stem; 3 parts of safflower; 4 parts of peach red; 4 parts of powder medicine; 4 parts of Chinese angelica root; 4 parts of clove; 3 parts of herba lycopi; 3 parts of radix angelicae pubescentis; 8 parts of cassia twig; 4 parts of camphor; and 2 parts of borneol.
4. The traditional Chinese medicine composition for treating tendons and collaterals relaxing, traumatic injury and sprain and rheumatalgia as claimed in claim 2 or 3, wherein the effective ingredients and pharmaceutically acceptable adjuvants are prepared into external liquid preparation, spray, film agent, ointment, powder or gel.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010075986.4A CN111214598A (en) | 2020-01-23 | 2020-01-23 | A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain, and rheumatalgia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010075986.4A CN111214598A (en) | 2020-01-23 | 2020-01-23 | A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain, and rheumatalgia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111214598A true CN111214598A (en) | 2020-06-02 |
Family
ID=70811741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010075986.4A Pending CN111214598A (en) | 2020-01-23 | 2020-01-23 | A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain, and rheumatalgia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111214598A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413604A (en) * | 2001-10-24 | 2003-04-30 | 高大海 | Method for preparing medicine for treatment of arthralgia-syndrome pain disease |
CN108245600A (en) * | 2018-02-12 | 2018-07-06 | 黄洁清 | A kind of pharmaceutical composition and its preparation method and application |
CN109248240A (en) * | 2018-11-02 | 2019-01-22 | 云南康创生物医药科技孵化有限公司 | Pharmaceutical composition and preparation method thereof for traumatic injury |
-
2020
- 2020-01-23 CN CN202010075986.4A patent/CN111214598A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413604A (en) * | 2001-10-24 | 2003-04-30 | 高大海 | Method for preparing medicine for treatment of arthralgia-syndrome pain disease |
CN108245600A (en) * | 2018-02-12 | 2018-07-06 | 黄洁清 | A kind of pharmaceutical composition and its preparation method and application |
CN109248240A (en) * | 2018-11-02 | 2019-01-22 | 云南康创生物医药科技孵化有限公司 | Pharmaceutical composition and preparation method thereof for traumatic injury |
Non-Patent Citations (1)
Title |
---|
高洁: "跌打止痛酊治痛证", 《中成药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103272177B (en) | Traditional Chinese medicine composition for treating bone fracture | |
CN107158297B (en) | A kind of traditional Chinese medicine ointment for treating orthopedic pain and preparation method thereof | |
CN114452347A (en) | A composition for treating pain in neck, shoulder, waist and leg, and prolapse of lumbar intervertebral disc, and its preparation method | |
CN107007714B (en) | A topical medicated liquor with effect in promoting callus formation | |
CN109432269A (en) | A kind of Chinese medicine composition and preparation method, purposes | |
CN102028830B (en) | Black plaster for treating traumatic injury, fracture and lumbar intervertebral disc herniation and preparation method thereof | |
CN103876352B (en) | Knee braces for knee arthritis | |
CN111228445A (en) | Medicinal liquor for detumescence and stasis-removing for traumatic injury and preparation method thereof | |
CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
CN108310070B (en) | A Chinese medicinal composition for treating pain caused by hyperosteogeny of lumbar vertebra and cervical vertebra, and its preparation method | |
CN111214598A (en) | A Chinese medicinal composition for treating rigidity of muscles and activating collaterals, traumatic injury and sprain, and rheumatalgia | |
CN103690583A (en) | Medicinal liquor, and preparation method and application thereof | |
CN114028507A (en) | Preparation method of traditional Chinese medicine for treating lumbago | |
CN103830437B (en) | A kind of fumigation and wash method conditioning liquid for accelerating fracture detumescence | |
CN114053211A (en) | A kind of plaster composition and its preparation method and application | |
CN107998235B (en) | Compound Zhuang medicine for treating ankle sprain and preparation method thereof | |
CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
CN111228450A (en) | Traditional Chinese medicine bone disease formula | |
CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
CN110801479A (en) | Ointment for traumatic injury and sprain and preparation method thereof | |
CN115998829B (en) | Chinese medicinal powder for treating pain and application method thereof | |
CN117731712B (en) | Production method of traditional Chinese medicine tincture for promoting blood circulation and relaxing tendons | |
CN103751346B (en) | A kind of Chinese medicine composition for hernia of lumbar intervertebral disk low back lower limb fiber crops pain | |
CN117045729A (en) | Traditional Chinese medicine composition for treating closed soft tissue injury and preparation method thereof | |
CN105943643A (en) | Aiwei pain relieving powder and preparation process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200602 |
|
RJ01 | Rejection of invention patent application after publication |